BMS swooped on Karuna towards the end of last year, shortly after AbbVie agreed an $8.7 billion deal to acquire Cerevel ...

September is the perfect time to turn up the volume on conversations about Primary Biliary Cholangitis (PBC) and the symptoms ...

With 890 million people affected globally and 42% of American adults classified as obese, the allure of a "miracle" weight ...

In a landmark development, world leaders meeting at the United Nations officially adopted a political declaration on ...

It's a blow to the SCD community, as Oxbryta (voxelotor) was the first drug to reach the market that prevented sickle ...

One of the biggest market access stories this year has been the launch of Lilly Direct (and, subsequently, PfizerForAll .) ...

PiaSky's approval by the MHRA earlier this year was based on the COMMODORE study, which showed that the drug was equivalent ...

However, the UK’s innovative ‘Netflix style’ subscription model for antibiotics represents a groundbreaking approach to ...

AstraZeneca's EGFR inhibitor Tagrisso has been approved by the FDA for a new lung cancer indication that could make it a ...

After a long road that included a three-month delay as the agency pushed for additional data, the US FDA has approved Sanofi ...

J&J said its latest bankruptcy bid is backed by around 83% of the 60,000-plus claimants cited in lawsuits, who are claiming ...

Aurion Biotech has launched its cell therapy Vyznova for serious eye disorder bullous keratopathy in Japan, its debut market, ...